Please assess the completion status of the following clinical trial:

Trial Title: A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Successfully completed the parent study 990120~* Agreed to use highly effective (in the opinion of the principal investigator) contraceptive measures throughout the study~* Were able to comprehend and were willing to give written informed consent for participation in the study~Exclusion Criteria:~* Pregnant or breast-feeding~* Had a psychiatric disorder that interfered with the understanding and giving of informed consent or compliance with protocol requirements~* Had any other condition that reduced the chance of obtaining data (eg, known poor compliance)~* Participating in another investigational study at the time of study entry~* Had any unstable medical condition, defined as having been hospitalized within 28 days before day 1, or otherwise unstable in the judgment of the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- cinacalcet (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).